A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)

~7 mi. (Grand Rapids, Michigan, +144 more cities)

Cancer & Hematology Centers of Western Michigan ( Site 0018)

Clear Cell Renal Cell Carcinoma

belzutifan, +3 more drugs

immunotherapy, +1 more type

A Phase-3, Open-Label, Randomized Study of Dato-DXd Versus Investigator's Choice of Chemotherapy (ICC) in Participants With Inoperable or Metastatic HR-Positive, HER2-Negative Breast Cancer Who Have Been Treated With One or Two Prior Lines of Systemic Chemotherapy (TROPION-Breast01)

~7 mi. (Grand Rapids, Michigan, +126 more cities)

Research Site

ER Positive, +2 more biomarkers

Breast Carcinoma

datopotamab deruxtecan

targeted therapy

Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study

~7 mi. (Grand Rapids, Michigan, +523 more cities)

Spectrum Health at Butterworth Campus

Clear Cell Renal Cell Carcinoma

cabozantinib, +2 more drugs

immunotherapy, +1 more type

Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy

~7 mi. (Grand Rapids, Michigan, +744 more cities)

Helen DeVos Children's Hospital at Spectrum Health, +2 more facilities

Breast Carcinoma

axillary lymph node dissection, +1 more drug

radiation therapy, +1 more type

Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer

~7 mi. (Grand Rapids, Michigan, +269 more cities)

Spectrum Health at Butterworth Campus, +1 more facility

ER Positive, +1 more biomarker

Invasive Breast Carcinoma

radiation therapy, +1 more drug

radiation therapy

Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)

~7 mi. (Grand Rapids, Michigan, +226 more cities)

Cancer & Hematology Centers of Western Michigan ( Site 0013)

Prostate Adenocarcinoma

enzalutamide, +1 more drug

hormone therapy, +1 more type

Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma

~7 mi. (Grand Rapids, Michigan, +454 more cities)

Spectrum Health at Butterworth Campus, +1 more facility

Classical Hodgkin Lymphoma

brentuximab vedotin, +7 more drugs

chemotherapy, +3 more types

A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia

~7 mi. (Grand Rapids, Michigan, +173 more cities)

Helen DeVos Children's Hospital at Spectrum Health

B-Cell Lymphoblastic Leukemia/Lymphoma

asparaginase Erwinia chrysanthemi, +12 more drugs

chemotherapy, +2 more types

Capivasertib+Abiraterone as Treatment for Patients With Metastatic Hormone-sensitive Prostate Cancer and PTEN Deficiency

~7 mi. (Grand Rapids, Michigan, +332 more cities)

Research Site

PTEN Deficient Expression

Prostate Adenocarcinoma

abiraterone, +1 more drug

hormone therapy, +1 more type

Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung Cancer

~7 mi. (Grand Rapids, Michigan, +664 more cities)

Mercy Health Saint Mary's, +2 more facilities

PD-L1 High Expression (TPS >= 1%), +1 more biomarker

Non-Small Cell Lung Carcinoma

carboplatin, +2 more drugs

chemotherapy, +1 more type

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

~7 mi. (Grand Rapids, Michigan, +825 more cities)

Helen DeVos Children's Hospital at Spectrum Health, +2 more facilities

AKT1 Mutation, +91 more biomarkers

Breast Carcinoma, +3 more conditions

adavosertib, +26 more drugs

immunotherapy, +1 more type

Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer

~7 mi. (Grand Rapids, Michigan, +240 more cities)

Spectrum Health at Butterworth Campus

Endometrial Adenocarcinoma, +5 more conditions

carboplatin, +2 more drugs

chemotherapy, +1 more type